Transgender men, transmasculine, and nonbinary people experience barriers to accessing health care, especially services that are traditionally gendered, such as gynecological care. In addition, very little is understood how testosterone impacts several aspects of pelvic and sexual health, including genital atrophy, genital infections (like bacterial vaginosis and yeast infection), endometriosis, and polycystic ovarian syndrome (PCOS).
This study is specifically examining the experiences of transgender and nonbinary people who are currently using testosterone gender-affirming hormone therapy have in accessing gynecological care. We also hope to understand some of the barriers and facilitators of accessing care and gaps in provider knowledge and awareness. We hope that the findings from this study will help enhance medical care, resources, services, and support for transgender and nonbinary people.